Development and validation of deep learning classifiers to detect Epstein-Barr virus and microsatellite instability status in gastric cancer: a retrospective multicentre cohort study

Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 68, 394, 10.3322/caac.21492 De Mello, 2019, Current and future aspects of immunotherapy for esophageal and gastric malignancies, Am Soc Clin Oncol Educ Book, 39, 237, 10.1200/EDBK_236699 Kim, 2018, Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer, Nat Med, 24, 1449, 10.1038/s41591-018-0101-z Kohlruss, 2019, Prognostic implication of molecular subtypes and response to neoadjuvant chemotherapy in 760 gastric carcinomas: role of Epstein-Barr virus infection and high- and low-microsatellite instability, J Pathol Clin Res, 5, 227, 10.1002/cjp2.137 Pietrantonio, 2019, Individual patient data meta-analysis of the value of microsatellite instability as a biomarker in gastric cancer, J Clin Oncol, 37, 3392, 10.1200/JCO.19.01124 Kim, 2015, Deregulation of immune response genes in patients with Epstein-Barr virus-associated gastric cancer and outcomes, Gastroenterology, 148, 137, 10.1053/j.gastro.2014.09.020 Roh, 2019, Single patient classifier assay, microsatellite instability, and Epstein-Barr virus status predict clinical outcomes in stage II/III gastric cancer: results from CLASSIC trial, Yonsei Med J, 60, 132, 10.3349/ymj.2019.60.2.132 2014, Comprehensive molecular characterization of gastric adenocarcinoma, Nature, 513, 202, 10.1038/nature13480 Boland, 1998, A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer, Cancer Res, 58, 5248 Gulley, 2001, Molecular diagnosis of Epstein-Barr virus-related diseases, J Mol Diagn, 3, 1, 10.1016/S1525-1578(10)60642-3 Kather, 2019, Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer, Nat Med, 25, 1054, 10.1038/s41591-019-0462-y Kather, 2020, Development of AI-based pathology biomarkers in gastrointestinal and liver cancer, Nat Rev Gastroenterol Hepatol, 17, 591, 10.1038/s41575-020-0343-3 Fu, 2020, Pan-cancer computational histopathology reveals mutations, tumor composition and prognosis, Nat Cancer, 1, 800, 10.1038/s43018-020-0085-8 Kather, 2020, Pan-cancer image-based detection of clinically actionable genetic alterations, Nat Cancer, 1, 789, 10.1038/s43018-020-0087-6 Schmauch, 2020, A deep learning model to predict RNA-Seq expression of tumours from whole slide images, Nat Commun, 11, 10.1038/s41467-020-17678-4 Echle, 2020, Clinical-grade detection of microsatellite instability in colorectal tumors by deep learning, Gastroenterology, 159, 1406, 10.1053/j.gastro.2020.06.021 Yamashita, 2021, Deep learning model for the prediction of microsatellite instability in colorectal cancer: a diagnostic study, Lancet Oncol, 22, 132, 10.1016/S1470-2045(20)30535-0 Bilal, 2021, Novel deep learning algorithm predicts the status of molecular pathways and key mutations in colorectal cancer from routine histology images, medRxiv Yamashita, 2021, Learning domain-agnostic visual representation for computational pathology using medically-irrelevant style transfer augmentation, arXiv Wang, 2020, Microsatellite instability prediction of uterine corpus endometrial carcinoma based on H&E histology whole-slide imaging, 1289 Ke, 2020, A prediction model of microsatellite status from histology images, 334 Song, 2020, Clinically applicable histopathological diagnosis system for gastric cancer detection using deep learning, Nat Commun, 11, 10.1038/s41467-020-18147-8 Dislich, 2020, Preservation of Epstein-Barr virus status and mismatch repair protein status along the metastatic course of gastric cancer, Histopathology, 76, 740, 10.1111/his.14059 Bang, 2012, Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial, Lancet, 379, 315, 10.1016/S0140-6736(11)61873-4 Cunningham, 2006, Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer, N Engl J Med, 355, 11, 10.1056/NEJMoa055531 Hayashi, 2013, The superiority of the seventh edition of the TNM classification depends on the overall survival of the patient cohort: comparative analysis of the sixth and seventh TNM editions in patients with gastric cancer from Japan and the United Kingdom, Cancer, 119, 1330, 10.1002/cncr.27928 Polom, 2019, KRAS mutation in gastric cancer and prognostication associated with microsatellite instability status, Pathol Oncol Res, 25, 333, 10.1007/s12253-017-0348-6 Schlößer, 2015, Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinoma, OncoImmunology, 5 Liu, 2018, Comparative molecular analysis of gastrointestinal adenocarcinomas, Cancer Cell, 33, 721, 10.1016/j.ccell.2018.03.010 Bossuyt, 2015, STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies, BMJ, 351 Muti Dinis-Ribeiro, 2012, Endoscopy, 44, 74, 10.1055/s-0031-1291491 Bankhead, 2017, QuPath: open source software for digital pathology image analysis, Sci Rep, 7, 10.1038/s41598-017-17204-5 Macenko, 2009, A method for normalizing histology slides for quantitative analysis, 1107 Zhang, 2017, ShuffleNet: an extremely efficient convolutional neural network for mobile devices, arXiv Echle, 2020, Deep learning in cancer pathology: a new generation of clinical biomarkers, Br J Cancer, 124, 686, 10.1038/s41416-020-01122-x McCradden, 2020, Ethical limitations of algorithmic fairness solutions in health care machine learning, Lancet Digit Health, 2, e221, 10.1016/S2589-7500(20)30065-0 Fridman, 2012, The immune contexture in human tumours: impact on clinical outcome, Nat Rev Cancer, 12, 298, 10.1038/nrc3245 Smyth, 2020, Gastric cancer, Lancet, 396, 635, 10.1016/S0140-6736(20)31288-5